EDGAR Filing Documents for 0001193125-17-210999

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-210999

Filing Date

2017-06-23

Accepted

2017-06-23 06:10:05

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	d413741ds3.htm	S-3	256259
2	EX-5.1	d413741dex51.htm	EX-5.1	19209
3	EX-10.1	d413741dex101.htm	EX-10.1	9803
4	EX-10.2	d413741dex102.htm	EX-10.2	112122
5	EX-10.3	d413741dex103.htm	EX-10.3	112197
6	EX-10.4	d413741dex104.htm	EX-10.4	112586
7	EX-10.5	d413741dex105.htm	EX-10.5	112832
8	EX-10.6	d413741dex106.htm	EX-10.6	112089
9	EX-10.7	d413741dex107.htm	EX-10.7	111869
10	EX-23.1	d413741dex231.htm	EX-23.1	1567
11	GRAPHIC	g413741g19o58.jpg	GRAPHIC	38609
12	GRAPHIC	g413741g64q29.jpg	GRAPHIC	2526
13	GRAPHIC	g413741g84c69.jpg	GRAPHIC	1346
	Complete submission text file	0001193125-17-210999.txt		1020384

Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063

Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206

REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)